References
1. Rauf A., Imran M., Suleria H.A.R., Ahmad B., Peters D.G., Mubarak M.S. A comprehensive review of the health perspectives of resveratrol. Food Funct. 2017; 8 (12): 4284–305. DOI: https://doi.org/10.1039/c7fo01300k
2. Malaguarnera L. Influence of resveratrol on the immune response. Nutrients. 2019; 11 (5): 946. DOI: https://doi.org/10.3390/nu11050946
3. Longo N., Frigeni M., Pasquali M. Carnitine transport and fatty acid oxidation. Biochim Biophys Acta Mol Cell Res. 2016; 1863 (10): 2422–35. DOI: https://doi.org/10.1016/j.bbamcr.2016.01.023
4. Panchal S.K., Poudyal H., Ward L.C., Waanders J., Brown L. Modulation of tissue fatty acids by L-carnitine attenuates metabolic syndrome in diet-induced obese rats. Food Funct. 2015; 6 (8): 2496–506. DOI: https://doi.org/10.1039/c5fo00480b
5. Wang S., Xu J., Zheng J., Zhang X., Shao J., Zhao L., Hao J. Anti-inflammatory and antioxidant effects of acetyl-l-carnitine on atherosclerotic rats. Med Sci Monit. 2020; 26: e920250. DOI: https://doi.org/10.12659/MSM.920250
6. Traina G. The neurobiology of acetyl-L-carnitine. Front Biosci (Landmark Ed). 2016; 21: 1314–29. DOI: https://doi.org/10.2741/4459
7. Ma S., Feng J., Zhang R., Chen J., Han D., Li X., et al. SIRT1 Activation by resveratrol alleviates cardiac dysfunction via mitochondrial regulation in diabetic cardiomyopathy mice. Oxid Med Cell Longev. 2017; 2017: 4602715. DOI: https://doi.org/10.1155/2017/4602715
8. Saqib U., Kelley T.T., Panguluri S.K., Liu D., Savai R., Baig M.S., et al. Polypharmacology or promiscuity? Structural interactions of resveratrol with its bandwagon of targets. Front Pharmacol. 2018; 9: 1201. DOI: https://doi.org/10.3389/fphar.2018.01201
9. Misawa T., Saitoh T., Kozaki T., Park S., Takahama M., Akira S. Resveratrol inhibits the acetylated-tubulin-mediated assembly of the NLRP3-inflammasome. Int Immunol. 2015; 27: 425–34. DOI: https://doi.org/10.1093/intimm/dxv018
10. Guide for the care and use of laboratory animals. 8th ed. In: Committee for the Update of the Guide for the Care and Use of Laboratory Animals; Institute for Laboratory Animal Research (ILAR); Division on Earth and Life Studies (DELS); National Research Council of the national academies. Washington: The National Academies Press, 2011.
11. Shipelin V.A., Shumakova A.A., Semin M.O., Trusov N.V., Balakina A.S., Timonin A.N., et al. Influence of the L-carnitine and resveratrol complex on physiological, biochemical and morphological indicators of normal and obese rats. Voprosy pitaniia [Problems of Nutrition]. 2021; 90 (1): 15–32. DOI: https://doi.org/10.33029/0042-8833-2021-90-1-15-32 (in Russian)
12. Apryatin S.A., Shipelin V.A., Trusov N.V., Mzhelskaya K.V., Evstratova V.S., Kirbaeva N.V., et al. Comparative analysis of the influence of a high-fat/high-carbohydrate diet on the level of anxiety and neuromotor and cognitive functions in Wistar and DAT-KO rats. Physiol Rep. 2019; 7 (4): e13987. DOI: https://doi.org/10.14814/phy2.13987
13. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001; 25 (4): 402–8. DOI: https://doi.org/10.1006/meth.2001.1262
14. Botros M., Sikaris K.A. The De Ritis ratio: the test of time. Clin Biochem Rev. 2013; 34: 117–30.
15. Mzhel’skaya K.V., Trusov N.V., Apryatin S.A., Soto C.J., Gmoshinski I.V., Tutel’yan V.A. Effect of quercetin on the expression of the carbohydrate and lipid metabolism genes in the liver of rats with genetic and alimentary obesity. Voprosy pitaniia [Problems of Nutrition]. 2019; 88 (2): 6–16. DOI: 10.24411/0042-8833-2019-10012 (in Russian)
16. Buqué X., Martínez M.J., Cano A., Miquilena-Colina M.E., García-Monzón C., Aspichueta P., et al. A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats. J Lipid Res. 2010; 51 (3): 500–13. DOI: https://doi.org/10.1194/jlr.M001966
17. Vilà L., Rebollo A., Ađalsteisson G.S., Alegret M., Merlos M., Roglans N., et al. Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment. Toxicol Appl Pharmacol. 2011; 251 (1): 32–40. DOI: https://doi.org/10.1016/j.taap.2010.11.011
18. Rutledge A.C., Khosrow A. Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutr Rev. 2007; 65 (6 pt 2): S13–23. DOI: https://doi.org/10.1111/j.1753-4887.2007.tb00322.x
19. Jiang F., Zhang Z., Zhang Y., Pan X., Yu L., Liu S. L-Carnitine ameliorates cancer cachexia in mice partly via the carnitine palmitoyltransferase-associated PPAR-γ signaling pathway. Oncol Res Treat. 2015; 38 (10): 511–6. DOI: https://doi.org/10.1159/000439550
20. Liu L., Zhang D.M., Wang M.X., Fan C.Y., Zhou F., Wang S.J., et al. The adverse effects of long-term l-carnitine supplementation on liver and kidney function in rats. Hum Exp Toxicol. 2015; 34 (11): 1148–61. DOI: https://doi.org/10.1177/0960327115571767
21. Dong W., Wang X., Bi S., Pan Z., Liu S., et al. Inhibitory effects of resveratrol on foam cell formation are mediated through monocyte chemotactic protein-1 and lipid metabolism-related proteins. Int J Mol Med. 2014; 33 (5): 1161–8. DOI: https://doi.org/10.3892/ijmm.2014.1680
22. Ardid-Ruiz A., Ibars M., Mena P., Del Rio D., Muguerza B., Arola L., et al. Resveratrol treatment enhances the cellular response to leptin by increasing OBRb content in palmitate-induced steatotic HepG2 cells. Int J Mol Sci. 2019; 20 (24): 6282. DOI: https://doi.org/10.3390/ijms20246282
23. Lin H.C., Chen Y.F., Hsu W.H., Yang C.W., Kao C.H., Tsai T.F. Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model. Cancer Prev Res. (Phila). 2012; 5 (7): 952–62. DOI: https://doi.org/10.1158/1940-6207.CAPR-12-0001
24. Mendes K.L., de Pinho L., Andrade J.M., Paraíso A.F., Lula J.F., Macedo S.M., et al. Distinct metabolic effects of resveratrol on lipogenesis markers in mice adipose tissue treated with high-polyunsaturated fat and high-protein diets. Life Sci. 2016; 153: 66–73. DOI: https://doi.org/10.1016/j.lfs.2016.04.014
25. Volkow N.D., Wang G.J., Baler R.D. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci. 2011; 15 (1): 37–46. DOI: https://doi.org/10.1016/j.tics.2010.11.001
26. Johansson M., Johansson N., Lund B.O. Xenobiotics and the glucocorticoid receptor: additive antagonistic effects on tyrosine aminotransferase activity in rat hepatoma cells. Basic Clin Pharmacol Toxicol. 2005; 96 (4): 309–15. DOI: https://doi.org/10.1111/j.1742-7843.2005.pto960406.x
27. Schwager J., Richard N., Widmer F., Raederstor D. Resveratrol distinctively modulates the inflammatory profiles of immune and endothelial cells. BMC Complement Altern Med. 2017; 17 (1): 309. DOI: https://doi.org/10.1186/s12906-017-1823-z
28. Ahmed S.M., Luo L., Namani A., Wang X.J., Tang X. Nrf2 signaling pathway: pivotal roles in inflammation. Biochim Biophys Acta Mol Basis Dis. 2017; 1863 (2): 585–97. DOI: https://doi.org/10.1016/j.bbadis.2016.11.005
29. Trusov N.V., Shipelin V.A., Mzhelskaya K.V., Shumakova A.A., Timonin A.N., Riger N.A., et al. Effect of resveratrol on behavioral, biochemical and immunological parameters of DBA/2J and tetrahybrid DBCB mice receiving diet with excess fat and fructose. J Nutr Biochem. 2021; 8: 108527. DOI: https://doi.org/10.1016/j.jnutbio.2020.108527
30. Trusov N.V., Mzhel’skaya K.V., Shipelin V.A., Shumakova A.A., Timonin A.N., Riger N.A., et al. The influence of l-carnitine on the immunological, integral and biochemical parameters of mice receiving a diet with excess of fat and fructose. Rossiyskiy fiziologicheskiy zhurnal imeni I.M. Sechenova [Russian Journal of Physiology named after I.M. Sechenov]. 2019; 105 (5): 619–33. DOI: https://doi.org/10.1134/S0869813919050121 (in Russian)